Dr. Carter is currently on the staff of the Sleep and Breathing Disorders Center at St. Paul University Hospital and the Director of the Sleep Medicine Fellowship Program of UT Southwestern. He was Chief of the Neurology and Sleep Medicine Section of the VA Medical Center in Dallas until August 30, 2009. At the VAMC he spent 25 years involved in basic and clinical research. After finishing his dissertation studies in monoamine metabolism in the neostriatum (Carter 1985), he has developed extensive experience in epilepsy, stroke, and clinical pharmacology. In the field of epilepsy, his research has included animal models of epileptogenesis (Carter & Warner, 1987, 1988, 1989) and human studies in epilepsy and antiepileptic drugs (Mattson, 1992 & 1996, Privitera,,1996). He has also served as principal investigator in a study of acute pharmacological intervention in new strokes (1995) and was a co-investigator in the NIH-sponsored ACE trial of aspirin and carotid endarterectomy, as well as, a NIAAA study of alcoholism. More recently he has been involved in applied research on the use of ambulatory cardiorespiratory sleep studies while continuing research in stroke.


Medical School
West Virginia University School of Medicine (1975)
West Virginia University School of Medicine (1979), Neurology
West Virginia University School of Medicine (1981), Neuropharmacology
Graduate School
West Virginia University School of Medicine (1985), Pharmacology

Research Interest

  • animal models of epileptogenesis
  • Antiplatelet therapy for the prevention of stroke and Novel methods for the detection of sleep disordered breathing
  • human studies in epilepsy and antiepileptic drugs
  • monoamine metabolism in the neostriatum


Featured Publications LegendFeatured Publications

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial.
Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators Lancet 1999 353 2179-2184
Topiramate placebo-controlled dose ranging trial in refractory partial epilepsy using 600,800, 1000 mg daily dosages.
Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R and the Topiramate YE Study Group Neurology 1996 46 1678-1683
Test-retest comparability and control subject data for the Rey-Auditory verbal learning test and Rey-Osterreith/Taylor complex figures.
Delaney RC, Prevey ML, Cramer JA, Mattson RH and the VA Epilepsy Cooperative Study #264 Group Archives of Clinical Neuropsychology 1992 7 1-6
A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic-clonic seizures in adults.
Mattson RH, Cramer JA, Collins JF, McCutchen CB, Mamdani MB, Davenport J, Lubozynski MF, Ramsey RE, Carter GS, Rowan AJ, Shin C, Browne TR, Ebersole JS, Treiman DM, Warner JJ, Smith DB, Fish SL, Rubino FA, Salinsky M, Scheyer RD, Wilder FJ New England Journal of Medicine 1992 327 765-771

Professional Associations/Affiliations

  • American Academy of Neurology
  • American Association of Electrodiagnostic Medicine
  • American Association of Sleep Medicine (Fellow)
  • American Clinical Neurophysiology Society (Fellow)
  • American Medical Association